No CrossRef data available.
Article contents
An expedited genes-to-drug approach using cryo-EM enabled structure based drug design
Published online by Cambridge University Press: 30 July 2021
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Cryo-EM in Drug Discovery
- Information
- Copyright
- Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of the Microscopy Society of America
References
GemSpot: A Pipeline for Robust Modeling of Ligands into CryoEM MapsGoogle Scholar
Robertson, Michael J., van Zundert, Gydo C. P., Borrelli, Kenneth, Georgios Skiniotis bioRxiv 750778; doi: https://doi.org/10.1101/750778CrossRefGoogle Scholar
Li, Qi, Pellegrino, Jenna, Lee, D. John, Tran, Arthur, Wang, Ruoxi, Park, Jesslyn, et al. (2019): Synthesis and Mechanism of Action of Group a Streptogramin Antibiotics That Overcome Resistance. ChemRxiv. Preprint. https://doi.org/vol.26434/chemrxiv.8346107.v2CrossRefGoogle Scholar
Wei, J, Leit, S, Kuai, J, Therrien, E, Rafi, S, Harwood, HJ Jr, DeLaBarre, B, Tong, L. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature. 2019 Apr;568(7753):566-570.CrossRefGoogle ScholarPubMed
You have
Access